Project Grant HT9425261E303
Award Date 7/15/26
Completion Date 7/14/29
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
- Federal Grant Award Summary The Trustees of Boston University received a $990,016 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective April 1, 2026 through March 31, 2029. The award supports research on biomaterial strategies designed to improve the specificity and efficacy of chimeric antigen receptor (CAR) T cell therapy for breast cancer treatment. This research initiative aligns with the DHA's mission to...
- Federal Project Grant Award Summary Boston University Medical Campus received a $6.52 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Brief Caspase Inhibition for Neuroprotection in Pediatric Cardiac Surgery," with an award date of August 1, 2025, and a performance period extending through July 31, 2029. This four-year research initiative will be conducted at the awardee's facility...
- The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
- Summary of Federal Project Grant Award The Defense Health Agency (DHA) awarded $997,393 in project grant funding to Boston VA Research Institute, Inc. under the Military Medical Research and Development program (CFDA 12.420) for a three-year research initiative entitled "Hemoglobin A1C Stability and Dementia in Older Adults with Diabetes." The award, effective July 1, 2026 through June 30, 2029, supports hypothesis-driven biomedical research designed to investigate the relationship...
- Federal Project Grant Award Summary The Trustees of Boston University received a $1.0 million Project Grant from the U.S. Army Research Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431) to support fundamental scientific investigation. The award, issued on March 16, 2026, with a performance period through March 15, 2027, funds research activities designed to advance long-term national security needs and enhance the Department of the Army's...
- The Trustees of Boston University will receive $330,000 from the Defense Health Agency under a Project Grant award to identify receptors for TDP-43 that mediate cellular uptake and neurotoxicity. This research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and other health...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a Project Grant valued at $834,915 under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2026, through April 30, 2028. The award supports the development of small molecules designed to disrupt TDP-43 (TAR DNA-binding protein 43) aggregation and restore protein function. This research addresses neurodegenerative disease mechanisms relevant to military health...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University Health Network (UHN) a $213,501 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025 through September 30, 2027. The research project, "Identification of Molecular Biomarkers for Invasive Glioblastoma Cell States and Tumor Microenvironment Modulation," will be conducted at UHN's facility in Ottawa, Ontario, Canada. This award supports...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital (MGH) a $1.35M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2029. The award funds research investigating metabolites and metabolic pathways in relation to Crohn disease risk, with research activities conducted at MGH's Boston, Massachusetts location. This biomedical research initiative aligns with the DHA's...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital $992,302 through the Military Medical Research and Development program (CFDA 12.420) on September 15, 2025, to support a three-year research project titled "Targeting MHCII Ubiquitination to Induce Immune Regulation in Vascularized Composite Tissue Transplantation." The project, which concludes on September 14, 2028, focuses on advancing biomedical research aimed at transforming...